ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICES LONG TERM RESULTS

Similar documents
Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding Raines D L, Dupont A W, Arguedas M R

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Beta-blocker plus nitrates for secondary prevention of variceal bleeding (Protocol)

th Annual AISF Meeting 44 th th th, 2011 Rome, February 23 rd -26

CARLO MERKEL, MASSIMO BOLOGNESI, DAVID SACERDOTI, GIANCARLO BOMBONATO, BARBARA BELLINI, RAFFAELLA BIGHIN, AND ANGELO GATTA

Variceal bleeding. Mainz,

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation

Safety and Efficacy of Iron Isomaltoside in Two Cases with Liver Cirrhosis and Iron Deficiency Anemia

Beta-blockers in cirrhosis: Cons

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

MEDICAL PROGRESS. Review Article. N Engl J Med, Vol. 345, No. 9 August 30,

NONSELECTIVE BETA-BLOCKERS IN PATIENTS WITH CIRRHOSIS: THE THERAPEUTIC WINDOW

Upper gastrointestinal bleeding in children. Nguyễn Diệu Vinh, MD Department of Gastroenterology

Carvedilol or Propranolol in the Management of Portal Hypertension?

Risk factors for 5-day bleeding after endoscopic treatments for gastroesophageal varices in liver cirrhosis

BETA-BLOCKERS IN CIRRHOSIS.PRO.

Evidence-Base Management of Esophageal and Gastric Varices

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices

Treatment of portal hypertension in the light of the Baveno VI Consensus Conference

Michele Bettinelli RN CCRN Lahey Health and Medical Center

Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis

Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS

Management of variceal bleeding Rachael Harry, MA, MRCP, and Julia Wendon, FRCP

Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters

Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis?

ICU Volume 14 - Issue 2 - Summer Matrix

A bleeding ulcer: What can the GP do? Gastrointestinal bleeding is a relatively common. How is UGI bleeding manifested? Who is at risk?

Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10-Year Experience in Gangwon Province, South Korea

HIV. KEY WORDS: HIV, esophageal varices, endoscopic injection sclerotherapy (EIS), endoscopic variceal ligation (EVL)

Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

The Value of Renal Artery Resistive Indices: Association with

Matching study design to research question-interactive learning session

The current recommended prophylaxis of variceal. Long-Term Follow-up of Hemodynamic Responders to Pharmacological Therapy After Variceal Bleeding

Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France

Variceal bleeding is a major cause of morbidity in patients

Incidence of large oesophageal varices in patients. bleeding. with cirrhosis: application to prophylaxis of first LIVER, BILIARY, AND PANCREAS

Portal hypertension is the pathophysiologic basis for

Care of the Patient With Cirrhosis

Natural history of α-1-atd in children

Index. Note: Page numbers of article titles are in boldface type.

Prevention of the development of varices and first portal hypertensive bleeding episode

Hemorragia por várices gastroesofágicas en la cirrosis

Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018

Chronic liver disease is a prevalent and clinically. Endoscopic Screening for Esophageal Varices in Cirrhosis: Is it Ever Cost Effective?

Supplemental Tables. Parasitic Schistosomiasis increase < 1. Genetic Hemochromatosis increase < 1. autoimmune Autoimmune hepatitis (AIH) increase < 1

Causes of Liver Disease in US

Transfusion strategies in patients with cirrhosis: less is more. 1. Department of Gastroenterology, Hillingdon Hospital, London, UK

Physician specialty and the outcomes and cost of admissions for end-stage liver disease Ko C W, Kelley K, Meyer K E

Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

Index. Note: Page numbers of article titles are in boldface type.

Comparison between Combination of Band ligation and Propranolol with Propranolol alone in Secondary Prophylaxis of Variceal bleed

ACUTE UPPER GASTROINTESTINAL HEMORRHAGE: PHARMACOLOGIC MANAGEMENT

VARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.

On-Call Upper GI Bleeding. Upper Gastrointestinal Bleeding

UGI Bleeding: Impact and Outcome of Early Endoscopy at the Referral Community Hospital ABSTRACT

Pediatric Gastroenterology

Hepatitis and pregnancy

Journal of American Science 2014;10(10)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

Chronic liver disease generally

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Introduction. Methods. Introduction. Methods. Methods. Journal reading Transfusion Strategies for Acute Upper Gastrointestinal Bleeding

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices

Upper Gastrointestinal Bleeding and the Importance of an Early Endoscopic Study for Diagnosis: A Retrospective Study

King Abdul-Aziz University Hospital (KAUH) is a tertiary

Healthy Liver Cirrhosis

Detection of Esophageal Varices Using CT and MRI

British Society of Gastroenterology. St. Elsewhere's Hospital. National Comparative Audit of Blood Transfusion

James Irwin Gastroenterology Department Palmerston North Hospital. Acute Medicine Meeting Hutt Hospital. June 21, 2015

V ariceal haemorrhage is a major cause of mortality and

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

Sangrado Gastrointestinal Alto Upper GI Bleeding

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes

Serag Esmat 1 and Dalia Omran 2

Submitted: Revised: Published:

Treatment of portal hypertension

Kathy P. Bull-Henry, MD, FACG Dr. Bull-Henry has indicated no relevant financial relationships. Don t Waste Time With No Chance to See

UPPER GASTROINTESTINAL BLEEDING; ENDOSCOPIC FINDINGS IN PATIENTS

Outcome and Characteristics of Patients on the Liver Transplant Waiting List: Shiraz Experience

U.I. Perfiliev, A.A. Yakovlev, U.U. Starovoitov, A.S. Volkov, I.G. Stolyarov

EDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem

Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid

CLINICAL MANAGEMENT Loren Laine, M.D. Clinical Management Editor University of Southern California Los Angeles, California

Life After SVR for Cirrhotic HCV

Wedged Hepatic Venous Pressure Adequately Reflects Portal Pressure in Hepatitis C Virus Related Cirrhosis

INTRODUCTION. Chung-Hwan Jun, Chang-Hwan Park, Wan-Sik Lee, Young-Eun Joo, Hyun-Soo Kim, Sung-Kyu Choi, Jong-Sun Rew, Sei-Jong Kim, Young-Dae Kim*

DIFFERENTIAL BENEFITS OF DAAs IN DIFFERENT PATIENT POPULATIONS. IN PATIENTS ON A WAITING LIST FOR TRANSPLANTATION. THE CLINIC.

Current status of hepatic surgery in Korea

Portal hypertension is the main complication of cirrhosis

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

age, serum levels of bilirubin, albumin, and aspartate aminotransferase

ACG Clinical Guideline: Management of Patients with Ulcer Bleeding

Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis

Variceal bleeding in cirrhotic patients

Clinical practice guidelines on the management of variceal bleeding

Transcription:

ENDOSCOPIC LIGATION OF ESOPHAGEAL VARICES LONG TERM RESULTS R. Nikolov, St.Ivan Rilski University Hospital, Clinic of Gastroenterology Sofia, Bulgaria, Medical University Sofia, Bulgaria Contact: R. Nikolov, Clinic of Gastroenterology, St. Ivan Rilski University Hospital 15, Acad. Ivan Geshov, 1431 Sofia, tel. +359 898547092, email: rosenknikolov@abv.bg Abstract: Materials and Methods: A retrospective analysis is presented of the long term results following 98 endoscopic ligation procedures of esophageal varices, performed on 76 patients, in the period 1999-2006. The patients were divided into two groups ones with history of esophageal varices haemorrhage treatment in a different medical facility and others with no history of such an incident. The procedures were conducted using Wilson-Cook manufactured ligation kit. The patients were primarily monitored 1 month after the ligation procedures and in the cases of good treatment effect - every 6 months afterwards. Results: The average follow up period after the first ligation procedure was 28 months ± 19 months. During this period, 9 patients had post-ligation variceal haemorrhage 1 directly after the procedure, 2 in the 20 th to the 30 th day interval after the procedure and 6 in the 12 th to the 25 th month interval after the endoscopic ligation. Lethal exitus, resulting from acute haemorrhage, occurred in 3 of these patients. From the whole studied group, 16 patients died during the follow up period, and in 13 of them the cause of death was liver failure. The six patients with delayed variceal haemorrhage recurrence for some reason did not comply with the follow up control medical visits. All of them were from the group with a history of esophageal variceal haemorrhage before the ligation procedures. Conclusions: 1. The endoscopic ligation is an effective method for primary and secondary prophylaxis of the esophageal variceal haemorrhage. 2. The long term results depend on the course of the main disease and the regular endoscopic follow up observation. 3. Patients with a history of variceal haemorrhage before the first ligation procedure have worse long term prognosis and the regular follow up endoscopic observation must be more strict. Original Paper Literature review The haemorrhage from gastroesophageal varices is one of the major complications of the portal hypertension. According to various studies, it is the reason for 10% to 30% of all the upper gastrointestinal haemorrhages. 1 Esophageal variceal haemorrhage occurs in 25-30% of all patients with liver cirrhosis and causes 80-90% of all the haemorrhages in these patients 2,3,4. The morbidity, mortality, and the cost-effectiveness of the treatment among these patients are higher, compared to those with other gastrointestinal haemorrhages 5,6,7. In around 30% of the cases the first variceal haemorrhage is lethal and 70% of the patients with history of such haemorrhage are about to have a recurrence 2,8. The therapeutic strategy for this condition includes prevention of the first variceal haemorrhage (primary prophylaxis), control and measures for ceasing the acute variceal bleeding, as well as prevention of haemorrhage recurrence (secondary prophylaxis) 2,8,9. The predictive criteria for an upcoming variceal haemorrhage are mostly clinical: worsening of liver function C class, according to the Child-Pugh classification, and/or continuous alcohol consumption; and endoscopic observation: large esophageal varices with red signs on their surface 2. Materials and Methods We conducted a retrospective analysis over 98 cases of endoscopic esophageal varices ligations, performed on 76 patients. In all of the procedures the Wilson-Cook manufactured endoscopic ligation apparatus was used. The endoscopic ligations were 27

performed between 1999 and 2006. The average follow up period after the first ligation procedure was 28 months ±19 months. The patients were divided into two groups ones without a history of variceal haemorrhage before the first ligation (primary prophylaxis group) and others with a history of such episodes (one or more), but without previous endoscopic ligation treatment for haemostasis. The average age of the patients was 59 ±33 years; 42 men and 34 women. The distribution of the patients, according to etiology and nosology is presented on table 1. All of the patients, who received endoscopic variceal ligation as a primary prophylaxis treatment, were with liver cirrhosis class C according to Child- Pugh classification. 98 endoscopic esophageal varices ligation procedures were performed on 76 patients. The distribution of the patients according to the number of endoscopic ligation procedures is presented on figure 1. During the follow up period, 9 patients had postligation variceal haemorrhage. The time between the conducted ligation and the post-ligation haemorrhage recurrence is presented on table 3. Follow up period scheme Endoscopic ligation follow up control fibrogastroscopy after 1 month, if residual varices 3 rd or 4 th grade and/or with red signs on surface, a new ligation is applied. If there is good treatment effect with none of the above residual characteristics follow up control fibrogastroscopy every 6 th month and continuous evaluation for new ligation is administered. Results The distribution of patients according to previous history of variceal haemorrhage before the ligation procedures is presented on table 2. Lethal exitus, resulting from acute haemorrhage occurred in 3 of these patients the patient with a recurrence right after the ligation procedure and 2 of those 6 patients with a delayed haemorrhage recurrence (12 th - 25 th month). From the whole studied group, 16 patients died during the follow up period 3 after an acute variceal haemorrhage and 13 as a result of liver failure. The distribution according to cause of death, etiology and number of ligation procedures is presented on table 4. When comparing the two major groups with primary and secondary prophylaxis of the variceal haemorrhage, it was found that only one patient from the group with no history of variceal haemorrhage before the ligation received such afterwards in the observed follow up period. This is presented on figure 2. 28

After the endoscopic ligation procedures, all the patients received treatment with propranolol and emergency treatment the result was lethal exitus. In 12 of the cases, there was a retrosternal pain lasting from 2 to 35 hours, which was successfully managed with analgetics and nitrates. 5 patients suffered nausea, which was overcome with gastrointestinal prokinetic drugs. Discussion proton /H+/ inhibitor PPI. The average daily dose of the propranolol was 35mg ±23mg and the PPI dose was 20mg daily. From the presented cases of primary and secondary prophylaxis of esophageal variceal haemorrhage through endoscopic ligation, 12% received postligation haemorrhage compared to the 25%-35% spontaneous variceal bleeding of patients with liver cirrhosis according to data in the literature 1. Only one of the patients from the primary prophylaxis group suffered a post-ligation haemorrhage, while in the secondary prophylaxis group there were 8 Complications resulting from the procedure. In one of the patients there was haemorrhage right after the ligation procedure. This patient was with heavy alcohol induced impairment of the behavioural control and refused any therapeutic cases with such haemorrhage (20%). These rates are significantly lower than the reported 70% recurrence in the spontaneous evolution of the disease 1,8. A strict evaluation and explicit conclusions are quite difficult a task, as the risk of a haemorrhage recurrence depends on many factors, such as: the course and 29

progression of the main disease; drug treatment and therapeutic scheme compliance; ceasing alcohol consumption; influence of all other possible Conclusions 1. The endoscopic ligation is an effective method for primary and secondary prophylaxis of the esophageal variceal haemorrhage. Primary prophylaxis Secondary prophylaxis 2. The long term results depend on the course of the main disease and the regular endoscopic follow up observation. 3. p<0.001 complications of the disease 2,8,9. A very important factor is the regular follow up fibrogastroscopic observations on the 1 st and if no progression on every 6 th month afterwards to ensure on time varices ligation if further needed. In the presented study, all of the six patients with delayed variceal haemorrhage recurrence for some reason did not comply with the follow up fibrogastroscopy controls and were admitted into hospital after the bleeding occurred. It is worth noting that the mortality from such haemorrhage (3 of the patients) is significantly lower than that from liver failure (13 patients) p<0.001. Patients with a history of variceal haemorrhage before the first ligation procedure have worse long term prognosis and the regular follow up endoscopic observation must be more strict. 30

Bibliography 1. Laine L. Upper gastrointestinal tract hemorrhage. West J Med 1991; 155:274-279. 2. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med 1988; 319:983-989. 3. Groszmann RJ, Bosch J, Grace ND, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401-1407. 4. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA, Langworthy A. Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989;96:1552-1559. 1. Mateva L, V.Dimitrova, A.Alexiev et al. Are healthy healthy volunteers? I. Ultrasound steatosis and signs of metabolic syndrome in healthy volunteers. J Clin Med 2009; this issue 2. Jelev D, A.Alexiev, V.Dimitrova et al. Are healthy healthy volunteers? II. Rate of serological markers for HBV infection. J Clin Med 2009; this issue 3. http://en.wikipedia.org/wiki/type_i_and_ type_ii_errors 4. http://www.stats.gla.ac.uk/steps/ glossary/hypothesis_testing.html#1err 5. http://en.wikipedia.org/wiki/bayesian_ inference 6. http://en.wikipedia.org/wiki/bayes _ theorem 5. Gralnek IM, Jensen DM, Kovacs TOG, et al. The economic impact of esophageal variceal hemorrhage: cost-effectiveness implications of endoscopic therapy. Hepatology 1999;29:44-50. 6. Burroughs AK, McCormick PA. Natural history and prognosis of variceal bleeding. Baillieres Clin Gastroenterol 1992;6:437-450. 7. Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic scleropathy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage: long-term follow-up. N Engl J Med 1987;316:11-15. 8. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800-809. 9. Villanueva, C., Minana, J., Ortiz, J., Gallego, A., Soriano, G., Torras, X., Sainz, S., Boadas, J., Cusso, X., Guarner, C., Balanzo, J. (2001). Endoscopic Ligation Compared with Combined Treatment with Nadolol and Isosorbide Mononitrate to Prevent Recurrent Variceal Bleeding. NEJM 345: 647-655 дивиди. За да се отговори на въпроса, са необходими адекватно поставени клинико-епидемиологични проучвания, които да поставят мост над пропастта между клиничната медицина и епидемиологията. Литература: 31